Cepheid Receives FDA Clearance for GBS Diagnostic Test
The FDA has cleared Xpert Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of GBS.
The FDA has cleared Xpert Xpress GBS, a dual-target molecular diagnostic test for the qualitative intrapartum detection of GBS.
The noninvasive method diagnoses atopic dermatitis by analyzing RNA from samples of sebum collected from infants using an oil-blotting film.
Sebia has announced the acquisition of Zeus Scientific, an In Vitro Diagnostic (IVD) company based in New Jersey.
The CDC launched a new report offering up-to-date county-level maps of seven different disease-causing germs or pathogens cause by ticks.
Read MoreThermo Scientific EliA RNA Pol III and EliA Rib-P tests have been cleared by the U.S. FDA for aiding in the diagnosis two autoimmune diseases.
Read MoreA next-gen sequencing test is facilitating treatment options and earlier diagnosis in family members who inherited a genetic abnormality.
Read MoreResearchers discovered potential lupus nephritis biomarkers that may be useful to develop more accurate clinical blood tests for the disease.
Read MoreData on a deadly tick-borne disease are being used to create models that could help predict, and possibly prevent, future outbreaks.
Read MoreMayo Clinic researchers validated a new antibody test to diagnose MS, a potentially disabling disease of the brain and spinal cord.
Read MoreSiemens Healthineers has received Breakthrough Device Designation from the FDA for the ADVIA Centaur sNfL assay.
Read MoreAntiphospholipid syndrome in children is often not identified until destructive clotting has already occurred.
Read MoreResearchers have developed a novel test that simplifies the allergy diagnosis and can reliably predict the success of a therapy.
Read MoreA new testing mechanism for Lyme disease can better identify the disease sooner, show when people are cured, and diagnose reinfection.
Read MoreEarly detection of tick-borne diseases can be tricky, but increased awareness and better diagnostics can help reduce false negatives.
Read MoreThe findings suggest that following current guidelines may lead to over-diagnoses in infants by labeling normal infant symptoms as possible milk allergies.
Read MoreCells from a cheek swab revealed biomarkers for rheumatoid arthritis that could lead to a way to diagnose and begin treatment before the disease develops.
Read MorePenicillin allergy testing during pregnancy may help avoid infant illness from infection, according to a new study from the ACAAI.
Read MoreThermo Scientific EliA SmDP-S test has been cleared by the FDA for aiding the diagnosis of SLE, the most common type of lupus.
Read More